Skip to main content
Equibles
JAZZ logo

JAZZ · Jazz Pharmaceuticals plc · Documents

Track JAZZ — free

Use JAZZ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research JAZZ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$241.55 +1.18 (+0.49%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$15.50B
Shares
64.19M
Volume · Nov 13 496.8K Avg daily vol (3M) 874.67K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022
May 4
Quarterly report 10-Q FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $813.72M ▲ 33.9% Net income $1.65M ▼ 98.6% Diluted EPS $0.03 ▼ 98.6%
Mar 1
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $3.09B ▲ 30.9% Net loss $329.67M Diluted EPS -$5.52
2021
Feb 23
Annual report 10-K FY2020, ended Dec 31
Annual report for FY2020
Revenue $2.36B ▲ 9.3% Net income $238.62M ▼ 54.4% Diluted EPS $4.22 ▼ 53.6%
2020
Nov 2
Quarterly report 10-Q FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $600.89M ▲ 11.8% Net income $148.23M ▲ 44.9% Diluted EPS $2.64 ▲ 48.3%
Showing 151–200 of 217 documents
Key facts CIK 1232524 CUSIP G50871105 13F (30d) 536 filings 485 filers Visit website Investor relations